You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
维亚生物(01873.HK)拟1.2亿元收购上海申裕导线100%股权
格隆汇 01-21 20:16

格隆汇1月21日丨维亚生物(01873.HK)公告,于2020年1月21日,公司间接全资附属公司维亚生物科技(上海)(作为买方)与卖方黄春艳及陶妹华订立股权转让协议,据此,维亚生物科技(上海)有条件同意自卖方收购目标公司上海申裕导线有限公司100%股权,代价为人民币1.2亿元。收购事项完成后,目标公司将成为本公司的间接全资附属公司。

目标公司为一间在中国成立的有限公司。于本公告日期,其注册资本为人民币859.14万元(已悉数缴足)。其目前并无实质业务经营活动,物业为其主要资产。

集团为中国的综合药物开发平台并正以年租金约人民币1150万元租用物业。其认为收购事项将令本集团实现其业务发展规划,节省租赁开支并为本集团提供稳定办公及营运场所。预计物业将由本集团持有自用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account